The cardiomyopathies constitute a group of diseases in which the main feature is direct involvement of the heart’s muscle itself. They are distinctive because they are not the result of pericardial, hypertensive, congenital, valvular, or ischemic diseases.
The cardiovascular system (CVS) consists of the heart, lungs and blood vessels. It is responsible for transportation of vital nutrients, gases and hormones throughout the body. The heart functions as the central pump with the blood vessels the pipes of the body. The CVS is controlled by a number of internal and external systems, which keep the CVS in balance with the needs of the body.
The heart is a pear shaped organ positioned centrally within the chest cavity with the apex extending over to the left nipple. The heart is a divided into a right and left side, each side has an atrium and ventricle. Heart valves and the contraction of the heart muscle control blood flow through the heart. The right side receives de-oxygenated blood from the major veins of the body and pumps this blood into the lungs. The left side of the heart then receives oxygen rich blood from the lungs and pumps this blood into the Aorta and arteries of the body. This pumping action is a complex well-coordinated activity that cannot be fully explained here. The heart receives its blood supply via the left and right coronary arteries.

May be a result of:
Top ^
There are a wide variety of reasons that cardiomyopathies may develop. The cardiomyopathies can be classified into number of different broad categories. There are also specific cardiomyopathies that exist.
Dilated cardiomyopathy- DCM (see picture B)
. Hypertrophic cardiomyopathy (see picture C)
Restrictive cardiomyopathy (see picture D)
Arrhythmogenic right ventricular cardiomyopathy
Ischaemic cardiomyopathy
Unclassified cardiomyopathy
Top ^
When a person is admitted with a diagnosis of cardiomyopathy the main aims of therapy are to rest the person, to reduce the workload of the heart and to improve the pumping ability of the heart. This treatment is generally drug therapy, which aids in improving the pumping action of the heart muscle and treatment to ensure the proper volume of blood in the body. Patients may be admitted to either an Intensive care Unit or a Coronary Care Unit depending on the situation.
Top ^
|
|
Top ^
Treatment of the patient will depend on the severity of their presentation. Patients with mild to moderate symptoms will generally be managed by the cardiac team in a coronary care unit (or combined ICU/CCU). However some patients may present with severe symptoms and may require the full support of an ICU. Close monitoring of vital signs will be done using a bedside monitor and oxygen saturation monitor. In more severe cases an arterial line and a pulmonary artery catheter may be required. Non-invasive ventilation using a CPAP machine (mask attached to a breathing machine) may be used for patients with acute pulmonary oedema. Occasionally a patient will need full respiratory support using an endotracheal tube (breathing tube) and ventilator (the breathing machine). In a number of cases where heart failure from the cardiomyopathy is extremely severe the doctors use mechanical devices to improve cardiac output (amount of blood the heart can pump) such as an intra aortic balloon pump (IABP) or a ventricular assist device (VAD)
A variety of drug therapies are used to treat heart failure:
Top ^
The time that the person will remain in Intensive Care or Coronary Care will vary depending on the prognosis of the patient. The prognosis of patients with heart failure depends primarily on the nature of the underlying heart disease and if the precipitating factor bringing the person into hospital can be treated effectively. Some patients with severe heart failure may require to be put on a waiting list for a heart transplant. The team of specialist doctors and Nurses working in the Intensive Care Unit will be able to help give you information on each specific case.
Top ^
The information contained in this sheet is general in nature and therefore cannot reflect individual patient variation. It is meant as a back up to specific information which will be discussed with you by the Doctors and Nurses caring for your loved one. ICCMU attests to the accuracy of the information contained here BUT takes no responsibility for how it may apply to an individual patient. Please refer to the Disclaimer
Heart Failure Version 1 (Authors Mark Mclennan CNC NRAHS and Kaye Rolls CNC ICCMU)
Top ^
In collaboration with the Community and ICU Clinicians, the Intensive Care Coordination & Monitoring Unit (ICCMU) and NSWHealth are committed to promoting excellence across Intensive Care services throughout the State. © ICCMU, NSWHealth.